Cargando…
Emerging point‐of‐care autologous cellular therapy using adipose‐derived stromal vascular fraction for neurodegenerative diseases
Neurodegenerative disorders are characterized by the gradual decline and irreversible loss of cognitive functions and CNS structures. As therapeutic recourse stagnates, neurodegenerative diseases will cost over a trillion dollars by 2050. A dearth of preventive and regenerative measures to hinder re...
Autores principales: | Al‐kharboosh, Rawan, Perera, Jonathan Jude, Bechtle, Alexandra, Bu, Guojun, Quinones‐Hinojosa, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736801/ https://www.ncbi.nlm.nih.gov/pubmed/36495120 http://dx.doi.org/10.1002/ctm2.1093 |
Ejemplares similares
-
Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy
por: Al-kharboosh, Rawan, et al.
Publicado: (2020) -
Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata
por: Anderi, Rami, et al.
Publicado: (2018) -
Current use of autologous adipose tissue-derived stromal vascular fraction cells for orthopedic applications
por: Pak, Jaewoo, et al.
Publicado: (2017) -
Autologous adipose-derived stromal vascular fraction and platelet concentrates for the treatment of complex perianal fistulas
por: Tutino, R., et al.
Publicado: (2022) -
Autologous Adipose-Derived Tissue Stromal Vascular Fraction (AD-tSVF) for Knee Osteoarthritis †
por: Vargel, İbrahim, et al.
Publicado: (2022)